ASN Kidney Translation Series: Artificial Intelligence in Nephrology

Dr. Oyindamola Christiana Adebayo discusses the results of her study, "Expression of Apolipoprotein L1 Risk Variants at the Plasma Membrane and Haplotype-Dependent Cytotoxicity," on behalf of her coauthors, with JASN Deputy Editor David H. Ellison.

ASN Kidney Translation explores advances in Cardiovascular-Kidney-Metabolic syndrome, including building a cardio-nephrology service (Kidney360), cardiorenal benefits of SGLT2 inhibitors & GLP-1 receptor agonists (JASN), & PREVENT risk prediction (CJASN).

Dr. Fan-Chi Chang discusses findings from her study, "Cell-Specific Roles of Angiopoietin-2 in CKD," with JASN Deputy Editor Alan S.L. Yu.

Drs. Benjamin Catanese and Daniel Edmonston discuss their study, "Cardiovascular Outcomes among New Users of GLP-1 Receptor Agonists Compared with DPP-4 Inhibitors and Sulfonylureas in Kidney Failure," with JASN Deputy Editor Manjula Kurella Tamura.

This ASN Kidney Translation Podcast episode covers advances in artificial intelligence: ASN Workgroup on AI (JASN), AI in nephrology education (CJASN), and ethical issues in AI (K360).

Drs. Gregory Hundemer and Rémi Goupil discuss the results of their study, "Subclinical Primary Aldosteronism and eGFR Decline Over Time," with JASN Deputy Editor David H. Ellison.

ASN Kidney Translation Podcast episode covers advances in peritoneal dialysis: genetic determinants of ultrafiltration (JASN), fungus-derived ergothioneine depletion in PD (K360), and a survey of PD use in the Veterans Health Administration (CJASN).

Dr. Christopher Knapp discusses the findings of his study, "Peritoneal Dialysis Initiation Patterns by Health Service Area during an Era of Expansion," with JASN Deputy Editor Manjula Kurella Tamura.

The authors of the ASN Kidney Health Guidance on Conservative Management in People with Kidney Failure discuss optimal approaches to addressing and providing a care path for patients who choose not to pursue dialysis. to support personalized patient care.

Drs. Morgan Gallazzini and Eloïse Marques discuss the results of their study, "Clustered Mitochondrial Homolog Inhibition by Lipocalin-2 Orchestrates Mitochondrial Disruption and Contributes to Kidney Disease," with JASN Deputy Editor Alan S.L. Yu.